FDA authorizes first interoperable insulin pump intended to allow patients to customize treatment through their individual diabetes management devices

FDA authorizes first interoperable insulin pump intended to allow patients to customize treatment through their individual diabetes management devices

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm631412.htm

Source: Food and Drug Administration - February 14, 2019 Category: American Health Source Type: news

More News: American Health | Diabetes | Endocrinology | Food and Drug Administration (FDA) | Insulin